About APCI

APCI logo

Not a member?
Join today!

(800) 532-2724

Since 1984, APCI has been the ‘united voice of independent pharmacy’

APCI began as a small buying group for a limited number of independent pharmacies in central Alabama. Since that time, the cooperative has grown to more than 1,800 members pharmacies in 26 states, and provides its members with a wide range of products and services.

Our mission is to represent the economic and professional interests of independent pharmacies by providing leadership, vision, and a collective voice for our members in the healthcare marketplace. Our goal is to level the playing field for our member pharmacies by providing innovative, targeted programs to benefit our entire membership.

10

Jan

2017

OutcomesMTM: Updated P&P Guide, new MTM opportunities, patient eligibility changes

Happy New Year! 

We are excited for another year of helping people through MTM. With the turn of the year, there a few important things to know. Refer to the alert on your Connect Platform dashboard for the full 2017 New Year notices.

Read More...

10

Jan

2017

Opus Health: Avion Ana-Lex, Derm and Prenate Updates 2017

OPUS Health would like to inform you of recent changes to the following Copay Assistance Program(s) (see list below). These changes can be viewed on the OPUS Health Pharmacy Portal. Please use the link below to log in and select View New or Modified Programs to view the new program. If you have already created an account, use the email address and password you created to log in. If you do not have an account, please click on the link below and select Create Account to register. Registering takes just a minute or two and provides access to this and all active programs ? even some printable offers you can provide for your pharmacy customers.
Read More...

10

Jan

2017

Opus Health: Lilly Cialis Copay Program Extension

OPUS Health would like to inform you of recent changes to the following Copay Assistance Program(s) (see list below). These changes can be viewed on the OPUS Health Pharmacy Portal. Please use the link below to log in and select View New or Modified Programs to view the new program. If you have already created an account, use the email address and password you created to log in. If you do not have an account, please click on the link below and select Create Account to register. Registering takes just a minute or two and provides access to this and all active programs ? even some printable offers you can provide for your pharmacy customers.

 

Read More...

10

Jan

2017

OptumRx: Opioid Use Following Buprenorphine (DDI POS Edit)

Effective January 1st 2017

Effective January 1, 2017, CMS will require Medicare plan sponsors to implement a soft point of sale (POS) reject when an opioid prescription is presented following the initiation of buprenorphine for the treatment of opioid use disorder. An enhancement to the Drug-Drug Interaction (DDI) cDUR edit will be turned on to reject opioid claims when a member has a recent history of treatment with buprenorphine or buprenorphine containing products indicated for opioid dependence.

*Please see attached PDF for more information.

Read More...

10

Jan

2017

OptumRx: Cigna Morphine Equivalent Dose Limit POS Edit (MEDLIMIT) & Cigna Opioid Use Following Buprenorphine (DDI POS Edit)

Effective January 1st 2017

Please see the attached PDF with important information regarding OptumRx: Cigna Morphine Equivalent Dose Limit POS Edit (MEDLIMIT) & Cigna Opioid Use Following Buprenorphine (DDI POS Edit).
Read More...
First 508509510511 Last